When was Zumutor founded?

Zumutor was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Zumutor located?

Zumutor is headquartered in Bengaluru, India.

Who is the current CEO of Zumutor?

Kavitha Iyer Rodrigues of Zumutor. They have also founded 1 company and are angel investors in 3 startups.

Which legal entities is Zumutor associated with?

Zumutor is associated with ZUMUTOR BIOLOGICS PRIVATE LIMITED and 1 other.

How many employees does Zumutor have?

As of Feb 28, 2025, Zumutor has 19 employees, reflecting a 54% year-over-year decline in headcount.

Is Zumutor a funded company?

Zumutor is a funded company, having raised a total of $35.2M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2013.

How much is Zumutor worth?

The latest valuation of Zumutor is $***** as of Apr 30, 2025. This marks a decline of 9% from its peak valuation of $40.9M in Nov, 2019. This marks a decline of 9% from its peak valuation of $40.9M in Nov, 2019.

When was the latest funding round of Zumutor?

Zumutor's latest funding was a $***** Series B round on Jun 13, 2026, with participation from 4 investors. Its primary sector is Immunotherapy. In India, the Immunotherapy sector has seen $19.8M in funding in 2026 to date.

What is the annual revenue of Zumutor?

Annual revenue of Zumutor is less than ₹10 Cr as on Mar 31, 2025

Where does Zumutor rank among its competitors?

Zumutor ranks 402nd amongst 3295 active competitors, of which 1129 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Zumutor, which secured $7.3M in Jun, 2026.

Who are the top competitors of Zumutor?

Zumutor's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Among them, Zumutor secured the most recent funding round in June, 2026.

Zumutor - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of novel immunotherapy and monoclonal antibody therapeutics. This company utilizes a proprietary human antibody platform to identify and develop first-in-class therapeutic antibodies. These antibodies target innate immunity and modulate the tumor microenvironment, focusing on targeted NK cell therapeutics within the immuno-oncology field. The company's approach centers on a platform for developing improved monoclonal antibody therapeutics. They maintain a commitment to scientific talent development within therapeutic research and development.

Website: zumutor.com
Social
Email ID: *****@zumutor.com, *****@zumutor.com
Phone Number: +91 **********

Key Metrics

Founded Year

2013

Location

Bengaluru, India

Stage

Series B

Total Funding

$35.2M in 9 rounds

Latest Funding Round

Series B, Jun 13, 2026, $*****

Post Money Valuation

$***** as on Apr 30, 2025

Investors

Accel & 19 more

Ranked

402^nd among 3295 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

19 as on Feb 28, 2025

Similar Companies

Zymeworks & 740 more

View Zumutor's full profile

Zumutor is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ZUMUTOR BIOLOGICS PRIVATE LIMITED CIN: U73200KA2015FTC081944 , India, Active	Jul 31, 2015	0 - ₹10 Cr (As on Mar 31, 2025)	19 (As on Apr 01, 2026)
Zumutor Biologics Inc. CIN: 5769405 , United States, Active	Jun 18, 2015	-	30 (As on May 31, 2022)	-

Zumutor has raised a total funding of $35.2M over 9 rounds. Its first funding round was on 2013. Its latest funding round was a Series B round on Jun 13, 2026 for $*****. 4 investors participated in its latest round. Zumutor has 14 institutional investors and 6 angel investors.

Here is the list of recent funding rounds of Zumutor:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 13, 2026	8105779	Series B	8113456	3621553	6892593	6742603
Nov 27, 2024	1212115	Series A	8595837	1248110	2517400	2715183
Feb 20, 2024	5240022	Series A	1989718	3850704	Bharat Innovation Fund	6724955

Access funding benchmarks and valuations. Sign up today!

View details of Zumutor's funding rounds and investors

The founders of Zumutor are Kavitha Iyer Rodrigues and Sohang Chatterjee. Kavitha Iyer Rodrigues is the CEO of Zumutor.

Here are the details of Zumutor's key team members:

Kavitha Iyer Rodrigues: Co-Founder & CEO of Zumutor. They are also an angel investor in 3 startups and serve on the boards of 2 companies.
Contact Info: 1 phone number
Sohang Chatterjee: Former Co-Founder of Zumutor and founder of 1 other company. They serve on the board of 1 company.

Zumutor's Board of Directors

Zumutor's board has 2 active members. Maloy Ghosh is part of team and Sunit Maity is independent board member.

Here is the list of Zumutor's board of directors:

Name	Type	Representing	Status	Duration
bp{lboe	Team	-	Past	2y 3m
dltrxdk	Team	-	Past	3y 9m
ptvneuh	Independent board member	-	Past	7y 5m

View details of Zumutor's Founder profiles and Board Members

Zumutor's employee count trend

Zumutor has 19 employees as of Feb 25. Here is Zumutor's employee count trend over the years:

Uncover Zumutor's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Zumutor include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Here is the list of Top 10 competitors of Zumutor, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Google Ventures, Baillie Gifford & 17 others	75/100
3rd	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Khosla Ventures & 23 others	71/100
402nd	Zumutor 2013, Bengaluru (India), Series B	Developer of novel immunotherapy and monoclonal antibody therapeutics	$35.2M	Accel, Premji Invest & 18 others	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Zumutor's competitors? Click here to see the top ones

Founders own 0.01%, Funds own 15.03%, Parent Entities (largest shareholder) own 83.32% and Angels own 1.66%. The net worth of Zumutor's founders is INR 2.66L as of Apr 30, 2025.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	0.01%	2.66L	0	0	0	0
Kavitha Iyer Rodrigues	0	0	0	0	0	0
Fund	15.03%	48Cr	7642673	8671558	9995305	6450283
Bharat Innovation Fund	6126033	4712007	8368216	5250472	3376504	7502286
Siana Capital	470	878	117	868	469	232
Parent Entity	83.32%	266Cr	1661043	9382037	4217152	6923238
Angel	1.66%	5.27Cr	6	5	4	5
Anand Suresh Deshpande	0	0	0	0	0	0
Total	100.00%	319Cr	3235627	8767171	1073433	5572488